메뉴 건너뛰기




Volumn 1, Issue 1, 2000, Pages 40-49

New targets for inhibitors of HIV-1 replication

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034304841     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35036060     Document Type: Review
Times cited : (172)

References (105)
  • 1
    • 2642709177 scopus 로고    scopus 로고
    • Declining morbidity and mortality, among patients with advanced human immunodeficiency virus infection
    • Palella, F. J. Jr et al. Declining morbidity and mortality, among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338, 853-860 (1998).
    • (1998) N. Engl. J. Med. , vol.338 , pp. 853-860
    • Palella Jr., F.J.1
  • 2
    • 0033587510 scopus 로고    scopus 로고
    • Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
    • Lucas, G. M., Chaisson, R. E. & Moore, R. D. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann. Intern. Med. 131, 81-87 (1999).
    • (1999) Ann. Intern. Med. , vol.131 , pp. 81-87
    • Lucas, G.M.1    Chaisson, R.E.2    Moore, R.D.3
  • 3
    • 0033612928 scopus 로고    scopus 로고
    • Transmission of antiretroviral-drug-resistant HIV-1 variants
    • Yerly, S. et al. Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet 354, 729-733 (1999).
    • (1999) Lancet , vol.354 , pp. 729-733
    • Yerly, S.1
  • 4
    • 0033609374 scopus 로고    scopus 로고
    • Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy
    • Furtado, M. R. et al. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy. W. Engl. J. Med. 340, 1614-1622 (1999).
    • (1999) W. Engl. J. Med. , vol.340 , pp. 1614-1622
    • Furtado, M.R.1
  • 5
    • 0033289665 scopus 로고    scopus 로고
    • Microbicides and barrier methods in HIV prevention
    • Van Damme, L. & Rosenberg, Z. F. Microbicides and barrier methods in HIV prevention. AIDS 13, S85-S92 (1999).
    • (1999) AIDS , vol.13
    • Van Damme, L.1    Rosenberg, Z.F.2
  • 6
    • 0031976829 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4-independent and gp120 dependent and requires cell surface heparans
    • Mondor, I., Ugolini, S. & Sattentau, Q. J. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4-independent and gp120 dependent and requires cell surface heparans. J. Virol. 72, 3623-3634 (1998).
    • (1998) J. Virol. , vol.72 , pp. 3623-3634
    • Mondor, I.1    Ugolini, S.2    Sattentau, Q.J.3
  • 7
    • 0033920212 scopus 로고    scopus 로고
    • Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
    • Moulard, M. et al. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74, 1948-1960 (2000).
    • (2000) J. Virol. , vol.74 , pp. 1948-1960
    • Moulard, M.1
  • 8
    • 0034598934 scopus 로고    scopus 로고
    • DC SIGN, a dendritic cell specific HIV-1-binding protein that enhances transinfection of T cells
    • Geijtenbeek, T. B. H. et al. DC SIGN, a dendritic cell specific HIV-1-binding protein that enhances transinfection of T cells. Cell 100, 575-585 (2000).
    • (2000) Cell , vol.100 , pp. 575-585
    • Geijtenbeek, T.B.H.1
  • 9
    • 0034009465 scopus 로고    scopus 로고
    • Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4
    • Liao, Z., Roos, J. W. & Hildreth, J. E. K. Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4. AIDS Res. Hum. Retroviruses 16, 355-366 (2000).
    • (2000) AIDS Res. Hum. Retroviruses , vol.16 , pp. 355-366
    • Liao, Z.1    Roos, J.W.2    Hildreth, J.E.K.3
  • 10
    • 0032921247 scopus 로고    scopus 로고
    • Cyanovirin-N binds to gp120 to interfere with CD4 dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120
    • Esser, M. T. et al. Cyanovirin-N binds to gp120 to interfere with CD4 dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J. Virol. 73, 4360-4371 (1999).
    • (1999) J. Virol. , vol.73 , pp. 4360-4371
    • Esser, M.T.1
  • 11
    • 0029731557 scopus 로고    scopus 로고
    • SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids
    • Delezay, O., Hammache, D., Fantini, J. & Yahi, N. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry 35, 15663-15671 (1996).
    • (1996) Biochemistry , vol.35 , pp. 15663-15671
    • Delezay, O.1    Hammache, D.2    Fantini, J.3    Yahi, N.4
  • 12
    • 0032543307 scopus 로고    scopus 로고
    • Structure of an HIV gp120 envelope glycoprotein complex with the CD4 receptor and a neutralizing human antibody
    • Kwong, P. D. et al. Structure of an HIV gp120 envelope glycoprotein complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659 (1998).
    • (1998) Nature , vol.393 , pp. 648-659
    • Kwong, P.D.1
  • 13
    • 17544388251 scopus 로고    scopus 로고
    • The bis-azo compound FP 21399 inhibits HIV-1 replication by preventing viral entry
    • Zhang, J. L. et al. The bis-azo compound FP 21399 inhibits HIV-1 replication by preventing viral entry. Virology 244, 530-541 (1998).
    • (1998) Virology , vol.244 , pp. 530-541
    • Zhang, J.L.1
  • 14
    • 0025987015 scopus 로고
    • Soluble CD4 and dextran sulphate mediate release of gp120 from HIV-1: Implications for clinical trials
    • Bugelski, P. J., Ellens, H., Hart, T. K. & Kirsh, R. L. Soluble CD4 and dextran sulphate mediate release of gp120 from HIV-1: Implications for clinical trials. J. Acq. Immun. Def. Synd. 4, 923-924 (1991).
    • (1991) J. Acq. Immun. Def. Synd. , vol.4 , pp. 923-924
    • Bugelski, P.J.1    Ellens, H.2    Hart, T.K.3    Kirsh, R.L.4
  • 15
    • 0033589780 scopus 로고    scopus 로고
    • Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4
    • Cabrera, C. et al. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4. AIDS Res. Hum. Retroviruses 15, 1535-1543 (1999).
    • (1999) AIDS Res. Hum. Retroviruses , vol.15 , pp. 1535-1543
    • Cabrera, C.1
  • 16
    • 0033914939 scopus 로고    scopus 로고
    • Single-dose safety, pharmacology and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults
    • Jacobson, J. M. et al. Single-dose safety, pharmacology and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults. J. Infect. Dis. 182, 326-329 (2000).
    • (2000) J. Infect. Dis. , vol.182 , pp. 326-329
    • Jacobson, J.M.1
  • 17
    • 0033587488 scopus 로고    scopus 로고
    • Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic
    • Zhang, W. et al. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Biochemistry 38, 9405-9416 (1999).
    • (1999) Biochemistry , vol.38 , pp. 9405-9416
    • Zhang, W.1
  • 18
    • 13044292627 scopus 로고    scopus 로고
    • Rational engineering of a miniprotein that reproduces the core of the.CD4 site interacting with HIV-1 envelope glycoprotein
    • Vita, C. et al. Rational engineering of a miniprotein that reproduces the core of the.CD4 site interacting with HIV-1 envelope glycoprotein. Prac. Natl Acad. Sci. USA 96, 13091-13096 (1999).
    • (1999) Prac. Natl Acad. Sci. USA , vol.96 , pp. 13091-13096
    • Vita, C.1
  • 19
    • 0030788879 scopus 로고    scopus 로고
    • A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties
    • Reimann, K. A. et al. A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties. AIDS Res. Hum. Retroviruses 13, 933-943 (1997).
    • (1997) AIDS Res. Hum. Retroviruses , vol.13 , pp. 933-943
    • Reimann, K.A.1
  • 20
    • 0031298109 scopus 로고    scopus 로고
    • HIV entry and tropism: The chemokine receptor connection
    • Berger, E. A. HIV entry and tropism: the chemokine receptor connection. AIDS 11, S3-S16 (1997).
    • (1997) AIDS , vol.11
    • Berger, E.A.1
  • 21
    • 17544384752 scopus 로고    scopus 로고
    • Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5Δ 32
    • Michael, N. L. et al. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5Δ 32. J. Virol. 72, 6040-6047 (1998).
    • (1998) J. Virol. , vol.72 , pp. 6040-6047
    • Michael, N.L.1
  • 22
    • 0033008471 scopus 로고    scopus 로고
    • Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1?
    • Zhang, Y.-J. & Moore, J. P. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1? J. Virol. 73, 3443-3448 (1999).
    • (1999) J. Virol. , vol.73 , pp. 3443-3448
    • Zhang, Y.-J.1    Moore, J.P.2
  • 23
    • 0032728566 scopus 로고    scopus 로고
    • Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo
    • Glushakova, S. et al. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J. Clin. Invest. 104, R7-R11 (1999).
    • (1999) J. Clin. Invest. , vol.104
    • Glushakova, S.1
  • 24
    • 0042376485 scopus 로고    scopus 로고
    • A new classification for HIV-1
    • Berger, E. A. et al. A new classification for HIV-1. Nature 391, 240 (1998).
    • (1998) Nature , vol.391 , pp. 240
    • Berger, E.A.1
  • 25
    • 0033986873 scopus 로고    scopus 로고
    • Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: Highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo
    • Veazey, R. S. et al. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J. Virol. 74, 57-64 (2000).
    • (2000) J. Virol. , vol.74 , pp. 57-64
    • Veazey, R.S.1
  • 27
    • 0001633495 scopus 로고    scopus 로고
    • Genetic restriction of HIV-1 infection and progression to AIDS by a deletion of the CKR5 structural allele
    • Dean, M. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion of the CKR5 structural allele. Science 273, 1856-1862 (1996).
    • (1996) Science , vol.273 , pp. 1856-1862
    • Dean, M.1
  • 28
    • 0030987288 scopus 로고    scopus 로고
    • CCR5 levels and expression pattern correlate with infectability by macrophage tropic HIV-1, in vitro
    • Wu, L. et al. CCR5 levels and expression pattern correlate with infectability by macrophage tropic HIV-1, in vitro. J. Exp. Med. 185, 1681-1691 (1997).
    • (1997) J. Exp. Med. , vol.185 , pp. 1681-1691
    • Wu, L.1
  • 29
    • 0032507962 scopus 로고    scopus 로고
    • Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
    • Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I. & Littman, D. R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599 (1998).
    • (1998) Nature , vol.393 , pp. 595-599
    • Zou, Y.R.1    Kottmann, A.H.2    Kuroda, M.3    Taniuchi, I.4    Littman, D.R.5
  • 30
    • 0029976181 scopus 로고    scopus 로고
    • Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry
    • Datema, R. et al. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob. Agents Chemother. 40, 750-754 (1996).
    • (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 750-754
    • Datema, R.1
  • 31
    • 0029417004 scopus 로고
    • - T cells
    • - T cells. Science 270, 1811-1815 (1995).
    • (1995) Science , vol.270 , pp. 1811-1815
    • Cocchi, F.1
  • 32
    • 0029775576 scopus 로고    scopus 로고
    • The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
    • Bleul, C. C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996).
    • (1996) Nature , vol.382 , pp. 829-833
    • Bleul, C.C.1
  • 33
    • 16044370087 scopus 로고    scopus 로고
    • The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1
    • Obertin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature 382, 833-835 (1996).
    • (1996) Nature , vol.382 , pp. 833-835
    • Obertin, E.1
  • 34
    • 0030951442 scopus 로고    scopus 로고
    • Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
    • Simmons, G. et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276, 276-279 (1997).
    • (1997) Science , vol.276 , pp. 276-279
    • Simmons, G.1
  • 35
    • 0032568336 scopus 로고    scopus 로고
    • Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides
    • Heveker, N. et al. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides. Curr. Biol. 8, 369-376 (1998).
    • (1998) Curr. Biol. , vol.8 , pp. 369-376
    • Heveker, N.1
  • 36
    • 0030745286 scopus 로고    scopus 로고
    • HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication
    • Amara, A. et al. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186, 139-146 (1997).
    • (1997) J. Exp. Med. , vol.186 , pp. 139-146
    • Amara, A.1
  • 37
    • 0032550337 scopus 로고    scopus 로고
    • Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
    • Mack, M. et al. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 187, 1215-1224 (1998).
    • (1998) J. Exp. Med. , vol.187 , pp. 1215-1224
    • Mack, M.1
  • 38
    • 0031963975 scopus 로고    scopus 로고
    • Genetic subtype independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines
    • Trkola, A. et al. Genetic subtype independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. J. Virol. 72, 396-404 (1998).
    • (1998) J. Virol. , vol.72 , pp. 396-404
    • Trkola, A.1
  • 39
    • 13144262826 scopus 로고    scopus 로고
    • + T cells: Role of signal transduction
    • + T cells: Role of signal transduction. Proc. NatlAcad. Sci. USA 95, 11880-11885 (1998).
    • (1998) Proc. NatlAcad. Sci. USA , vol.95 , pp. 11880-11885
    • Kinter, A.1
  • 40
    • 0345003718 scopus 로고    scopus 로고
    • Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication?
    • Marechal, V., Arenzana-Seisdedos, F., Heard, J.-M. & Schwartz, O. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication? J. Virol. 73, 3608-3615 (1999).
    • (1999) J. Virol. , vol.73 , pp. 3608-3615
    • Marechal, V.1    Arenzana-Seisdedos, F.2    Heard, J.-M.3    Schwartz, O.4
  • 41
    • 0032768967 scopus 로고    scopus 로고
    • The CC chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosoaminoglycans, and also activates a signal transduction pathway that enhances viral infectivity
    • Trkola, A. et al. The CC chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosoaminoglycans, and also activates a signal transduction pathway that enhances viral infectivity. J. Virol. 73, 6370-6379 (1999).
    • (1999) J. Virol. , vol.73 , pp. 6370-6379
    • Trkola, A.1
  • 42
    • 0032924183 scopus 로고    scopus 로고
    • Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants
    • Mosier, D. E. et al. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J. Virol. 73, 3544-3550 (1999).
    • (1999) J. Virol. , vol.73 , pp. 3544-3550
    • Mosier, D.E.1
  • 43
    • 16144365390 scopus 로고    scopus 로고
    • CD4-independent infection by HIV-2 is mediated by fusin/CXCR4
    • Endres, M. J. et al. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745-756 (1996).
    • (1996) Cell , vol.87 , pp. 745-756
    • Endres, M.J.1
  • 44
    • 0032902710 scopus 로고    scopus 로고
    • Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC chemokine activity by monoclonal antibodies to CCR5
    • Olson, W. C. et al. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC chemokine activity by monoclonal antibodies to CCR5. J. Virol. 73, 4145-4155 (1999).
    • (1999) J. Virol. , vol.73 , pp. 4145-4155
    • Olson, W.C.1
  • 45
    • 0030830661 scopus 로고    scopus 로고
    • Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
    • Schols, D. et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186, 1383-1388 (1997).
    • (1997) J. Exp. Med. , vol.186 , pp. 1383-1388
    • Schols, D.1
  • 46
    • 0030780377 scopus 로고    scopus 로고
    • A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
    • Murakami, T. et al. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J. Exp. Med. 186, 1389-1393 (1997).
    • (1997) J. Exp. Med. , vol.186 , pp. 1389-1393
    • Murakami, T.1
  • 47
    • 0030773515 scopus 로고    scopus 로고
    • A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
    • Doranz, B. J. et al. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J. Exp. Med. 186, 1395-1400 (1997).
    • (1997) J. Exp. Med. , vol.186 , pp. 1395-1400
    • Doranz, B.J.1
  • 48
    • 0031891516 scopus 로고    scopus 로고
    • AMD3100, a small molecule inhibitor of HPV-1 entry via the CXCR4 co-receptor
    • Donzella, G. A. et al. AMD3100, a small molecule inhibitor of HPV-1 entry via the CXCR4 co-receptor. Nature Med. 4, 72-77 (1998).
    • (1998) Nature Med. , vol.4 , pp. 72-77
    • Donzella, G.A.1
  • 49
    • 0032954383 scopus 로고    scopus 로고
    • T134, a small-molecule CXCR4 inhibitor, has no cross drug resistance with AMD3100, a CXCR4 antagonist with a different structure
    • Arakaki, R. et al. T134, a small-molecule CXCR4 inhibitor, has no cross drug resistance with AMD3100, a CXCR4 antagonist with a different structure. J. Virol. 73, 1719-1723 (1999).
    • (1999) J. Virol. , vol.73 , pp. 1719-1723
    • Arakaki, R.1
  • 50
    • 0031596253 scopus 로고    scopus 로고
    • T-tropic human immunodeficiency virus type 1 (HIV-1) derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection
    • Sakaida, H. et al. T-tropic human immunodeficiency virus type 1 (HIV-1) derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection. J. Virol. 72, 9763-9770 (1998).
    • (1998) J. Virol. , vol.72 , pp. 9763-9770
    • Sakaida, H.1
  • 51
    • 13044256383 scopus 로고    scopus 로고
    • A small molecule nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
    • Baba, M. et al. A small molecule nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl Acad. Sci. USA 96, 5698-5703 (1999).
    • (1999) Proc. Natl Acad. Sci. USA , vol.96 , pp. 5698-5703
    • Baba, M.1
  • 52
    • 14444282418 scopus 로고    scopus 로고
    • Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: A candidate for chemotherapeutic and microbicidal application
    • Howard, O. M. Z. et al. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: A candidate for chemotherapeutic and microbicidal application. J. Med. Chem. 41, 2184-2193 (1998).
    • (1998) J. Med. Chem. , vol.41 , pp. 2184-2193
    • Howard, O.M.Z.1
  • 53
    • 0026465468 scopus 로고
    • A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
    • Wild, C., Oas, T., McDanal, C., Bolognesi, D. & Matthews, T. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl Acad. Sci. USA 89, 10537-10541 (1992).
    • (1992) Proc. Natl Acad. Sci. USA , vol.89 , pp. 10537-10541
    • Wild, C.1    Oas, T.2    McDanal, C.3    Bolognesi, D.4    Matthews, T.5
  • 55
    • 0031962175 scopus 로고    scopus 로고
    • Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors
    • Jones, P. L., Korte, T. & Blumenthal, R. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273, 404-409 (1998).
    • (1998) J. Biol. Chem. , vol.273 , pp. 404-409
    • Jones, P.L.1    Korte, T.2    Blumenthal, R.3
  • 56
    • 0031729823 scopus 로고    scopus 로고
    • Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
    • Kilby, J. M. et al. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nature Med. 4, 1302-1307 (1998).
    • (1998) Nature Med. , vol.4 , pp. 1302-1307
    • Kilby, J.M.1
  • 57
    • 0032876381 scopus 로고    scopus 로고
    • Selection of gp41-mediated HIV-1 cell entry inhibition from biased combinational libraries of non-natural binding elements
    • Ferrer, M. et al. Selection of gp41-mediated HIV-1 cell entry inhibition from biased combinational libraries of non-natural binding elements. Nature Struct. Biol. 6, 953-959 (1999).
    • (1999) Nature Struct. Biol. , vol.6 , pp. 953-959
    • Ferrer, M.1
  • 58
    • 0033214895 scopus 로고    scopus 로고
    • Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled coil pocket
    • Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A. & Kim, P. S. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled coil pocket. Cell 99, 103-115 (1999).
    • (1999) Cell , vol.99 , pp. 103-115
    • Eckert, D.M.1    Malashkevich, V.N.2    Hong, L.H.3    Carr, P.A.4    Kim, P.S.5
  • 59
    • 0033981739 scopus 로고    scopus 로고
    • Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 env-mediated fusion depends on the sequence and accessibility of the gp41 loop region
    • Labrosse, B., Treboute, C. & Alizon, M. Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 env-mediated fusion depends on the sequence and accessibility of the gp41 loop region. J. Virol. 74, 2142-2150 (2000).
    • (2000) J. Virol. , vol.74 , pp. 2142-2150
    • Labrosse, B.1    Treboute, C.2    Alizon, M.3
  • 60
    • 0025281325 scopus 로고
    • The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope
    • Wilson, C. et al. The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope. J. Virol. 64, 3240-3248 (1990).
    • (1990) J. Virol. , vol.64 , pp. 3240-3248
    • Wilson, C.1
  • 61
    • 0032560463 scopus 로고    scopus 로고
    • A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV 1 envelope glycoprotein-mediated cell fusion
    • Pritsker, M., Jones, P., Blumenthal, R. & Shai, Y. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV 1 envelope glycoprotein-mediated cell fusion. Proc. Natl Acad. Sci. USA 95, 7287-7292 (1998).
    • (1998) Proc. Natl Acad. Sci. USA , vol.95 , pp. 7287-7292
    • Pritsker, M.1    Jones, P.2    Blumenthal, R.3    Shai, Y.4
  • 62
    • 0031883832 scopus 로고    scopus 로고
    • Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides
    • Rimsky, L. T., Shugars, D. C. & Matthews, T. J. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72, 986-993 (1998).
    • (1998) J. Virol. , vol.72 , pp. 986-993
    • Rimsky, L.T.1    Shugars, D.C.2    Matthews, T.J.3
  • 63
    • 0003973947 scopus 로고    scopus 로고
    • The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
    • De Vreese, K. et al. The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J. Virol. 70, 689-696 (1996).
    • (1996) J. Virol. , vol.70 , pp. 689-696
    • De Vreese, K.1
  • 64
    • 0031968673 scopus 로고    scopus 로고
    • T-cell-line tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1α contains mutations in the envelope gp120 but does not show a switch in coreceptor use
    • Schols, D., Esté, J. A., Cabrera, C. & De Clercq, E. T-cell-line tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1α contains mutations in the envelope gp120 but does not show a switch in coreceptor use. J. Virol. 72, 4032-4037 (1998).
    • (1998) J. Virol. , vol.72 , pp. 4032-4037
    • Schols, D.1    Esté, J.A.2    Cabrera, C.3    De Clercq, E.4
  • 65
    • 0033059948 scopus 로고    scopus 로고
    • Shift of clinical human immunodeficiency virus type 1 isolates from X4 to X5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4
    • Esté, J. A. et al. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to X5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4. J. Virol. 73, 5577-5585 (1999).
    • (1999) J. Virol. , vol.73 , pp. 5577-5585
    • Esté, J.A.1
  • 66
    • 0033937219 scopus 로고    scopus 로고
    • Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha
    • Maeda, Y., Foda, M., Matsushita, S. & Harada, S. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha. J. Virol. 74, 1787-1793 (2000).
    • (2000) J. Virol. , vol.74 , pp. 1787-1793
    • Maeda, Y.1    Foda, M.2    Matsushita, S.3    Harada, S.4
  • 67
    • 0027940713 scopus 로고
    • Specific incorporation of cyclophilin a into HIV-1 virions
    • Franke, E. K., Yuan, H. E. H. & Luban, J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359-362 (1994).
    • (1994) Nature , vol.372 , pp. 359-362
    • Franke, E.K.1    Yuan, H.E.H.2    Luban, J.3
  • 68
    • 0027971782 scopus 로고
    • Functional association of cyclophilin A with HIV-1 virions
    • Thali, M. et al. Functional association of cyclophilin A with HIV-1 virions. Nature 372, 363-365 (1994).
    • (1994) Nature , vol.372 , pp. 363-365
    • Thali, M.1
  • 69
    • 0029895725 scopus 로고    scopus 로고
    • Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that gag encodes functional target of cyclophilin A
    • Braaten, D. et al. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that gag encodes functional target of cyclophilin A. J. Virol. 70, 5170-5176 (1996).
    • (1996) J. Virol. , vol.70 , pp. 5170-5176
    • Braaten, D.1
  • 71
    • 0032993043 scopus 로고    scopus 로고
    • The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5′-end- And DNA 3′-end-directed RNase H activities
    • Gerondelis, P. et al. The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5′-end-and DNA 3′-end-directed RNase H activities. J. Virol. 73, 5803-5813 (1999).
    • (1999) J. Virol. , vol.73 , pp. 5803-5813
    • Gerondelis, P.1
  • 72
    • 0029585377 scopus 로고
    • First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses
    • Darlix, J. L., Lapadat-Tapolsky, M., de Rocquigny, H. & Roques, B. P. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254, 523-537 (1995).
    • (1995) J. Mol. Biol. , vol.254 , pp. 523-537
    • Darlix, J.L.1    Lapadat-Tapolsky, M.2    De Rocquigny, H.3    Roques, B.P.4
  • 73
    • 0030019808 scopus 로고    scopus 로고
    • The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti- HIV activity
    • Tummino, P. J. et al. The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. Proc. Natl Acad. Sci. USA 93, 969-973 (1996).
    • (1996) Proc. Natl Acad. Sci. USA , vol.93 , pp. 969-973
    • Tummino, P.J.1
  • 74
    • 0028875771 scopus 로고
    • Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS
    • Rice, W. G. et al. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270, 1194-1197 (1995).
    • (1995) Science , vol.270 , pp. 1194-1197
    • Rice, W.G.1
  • 75
    • 0033552881 scopus 로고    scopus 로고
    • Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers
    • Turpin, J. A. et al. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. J. Med. Chem. 42, 67-86 (1999).
    • (1999) J. Med. Chem. , vol.42 , pp. 67-86
    • Turpin, J.A.1
  • 76
    • 0031956156 scopus 로고    scopus 로고
    • Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication
    • Tanchou, V. et al. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication. J. Virol. 72, 4442-4447 (1998).
    • (1998) J. Virol. , vol.72 , pp. 4442-4447
    • Tanchou, V.1
  • 77
    • 0032776165 scopus 로고    scopus 로고
    • Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: Stimulation by the viral nucleocapsid protein
    • Carteau, S., Gorelick, R. J. & Bushman, F. D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J. Virol. 73, 6670-6679 (1999).
    • (1999) J. Virol. , vol.73 , pp. 6670-6679
    • Carteau, S.1    Gorelick, R.J.2    Bushman, F.D.3
  • 78
    • 0344671562 scopus 로고    scopus 로고
    • Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication
    • Berthoux, L., Pechoux, C. & Darlix, J. L. Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication. J. Virol. 73, 10000-10009 (1999).
    • (1999) J. Virol. , vol.73 , pp. 10000-10009
    • Berthoux, L.1    Pechoux, C.2    Darlix, J.L.3
  • 79
    • 0025342694 scopus 로고
    • HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
    • Zack, J. A. et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990).
    • (1990) Cell , vol.61 , pp. 213-222
    • Zack, J.A.1
  • 80
    • 0025238945 scopus 로고
    • HIV-1 replication is controlled at the level of T cell activation and proviral integration
    • Stevenson, M., Stanwick, T. L. Dempsey, M. P. & Lamonica, C. A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551-1560 (1990).
    • (1990) EMBO J. , vol.9 , pp. 1551-1560
    • Stevenson, M.1    Stanwick, T.L.2    Dempsey, M.P.3    Lamonica, C.A.4
  • 81
    • 0032567042 scopus 로고    scopus 로고
    • Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells
    • Kinoshita, S., Chen, B. K., Kaneshima, H. & Nolan, G. P. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95, 595-604 (1998).
    • (1998) Cell , vol.95 , pp. 595-604
    • Kinoshita, S.1    Chen, B.K.2    Kaneshima, H.3    Nolan, G.P.4
  • 82
    • 0025871394 scopus 로고
    • Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporine A
    • Flanagan, W. M., Corthesy, B., Bram, R. J. & Crabtree, G. R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporine A. Nature 352, 803-807 (1991).
    • (1991) Nature , vol.352 , pp. 803-807
    • Flanagan, W.M.1    Corthesy, B.2    Bram, R.J.3    Crabtree, G.R.4
  • 83
    • 0034646513 scopus 로고    scopus 로고
    • HIV-1 genome nuclear import is mediated by a central DNa flap
    • Zennou, V. et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173-185 (2000).
    • (2000) Cell , vol.101 , pp. 173-185
    • Zennou, V.1
  • 84
    • 0027965903 scopus 로고
    • HIV-1 reverse transcription. A termination step at the center of the genome
    • Charneau, P. et al. HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241, 651-662 (1994).
    • (1994) J. Mol. Biol. , vol.241 , pp. 651-662
    • Charneau, P.1
  • 85
    • 0027199982 scopus 로고
    • Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection
    • Bukrinsky, M. I. et al. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl Acad. Sci. USA 90, 6125-6129 (1993).
    • (1993) Proc. Natl Acad. Sci. USA , vol.90 , pp. 6125-6129
    • Bukrinsky, M.I.1
  • 86
    • 0031603418 scopus 로고    scopus 로고
    • Retroviral cDNA integration: Mechanism, applications and inhibition
    • Hansen, M. S., Carteau, S., Hoffmann, C., Li, L. & Bushman, F. Retroviral cDNA integration: mechanism, applications and inhibition. Genet. Eng. 20, 41-61 (1998).
    • (1998) Genet. Eng. , vol.20 , pp. 41-61
    • Hansen, M.S.1    Carteau, S.2    Hoffmann, C.3    Li, L.4    Bushman, F.5
  • 87
    • 0028924020 scopus 로고
    • Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells
    • Wiskerchen, M. & Muesing, M. A. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 69, 376-386 (1995).
    • (1995) J. Virol. , vol.69 , pp. 376-386
    • Wiskerchen, M.1    Muesing, M.A.2
  • 88
    • 0031060473 scopus 로고    scopus 로고
    • Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds
    • Hazuda, D. et al. Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds. J. Virol. 71, 807-811 (1997).
    • (1997) J. Virol. , vol.71 , pp. 807-811
    • Hazuda, D.1
  • 89
    • 14444276046 scopus 로고    scopus 로고
    • Salicylhydrazine-containing inhibitors of HIV-1 integrase: Implication for a selective chelation in the integrase active site
    • Neamati, N. et al. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. J. Med. Chem. 41, 3202-3209 (1998).
    • (1998) J. Med. Chem. , vol.41 , pp. 3202-3209
    • Neamati, N.1
  • 90
    • 0034723439 scopus 로고    scopus 로고
    • Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
    • Hazuda, D. J. et al. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 287, 646-650 (2000).
    • (2000) Science , vol.287 , pp. 646-650
    • Hazuda, D.J.1
  • 91
    • 0030987672 scopus 로고    scopus 로고
    • HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
    • Gallay, P., Hope,T., Chin, D. & Trono, D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl Acad. Sci. USA 94, 9825-9830 (1997).
    • (1997) Proc. Natl Acad. Sci. USA , vol.94 , pp. 9825-9830
    • Gallay, P.1    Hope, T.2    Chin, D.3    Trono, D.4
  • 92
    • 0033526522 scopus 로고    scopus 로고
    • Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein
    • Pluymers, W., Cherepanov, P., Schols, D., De Clercq, E. & Debyser, Z. Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein. Virology 258, 327-332 (1999).
    • (1999) Virology , vol.258 , pp. 327-332
    • Pluymers, W.1    Cherepanov, P.2    Schols, D.3    De Clercq, E.4    Debyser, Z.5
  • 93
    • 0347120545 scopus 로고    scopus 로고
    • HIV nuclear import: What's all the flap?
    • Stevenson, M. HIV nuclear import: What's all the flap? Nature Med. 6, 9-10 (2000).
    • (2000) Nature Med. , vol.6 , pp. 9-10
    • Stevenson, M.1
  • 94
    • 0034717161 scopus 로고    scopus 로고
    • Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site specific photocrosslinking
    • Rausch, J. W., Sathyanaryana, B. K., Bona, M. K. & Le Grice, S. F. Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site specific photocrosslinking. J. Biol. Chem. 3, 16015-16022 (2000).
    • (2000) J. Biol. Chem. , vol.3 , pp. 16015-16022
    • Rausch, J.W.1    Sathyanaryana, B.K.2    Bona, M.K.3    Le Grice, S.F.4
  • 95
    • 0031788565 scopus 로고    scopus 로고
    • Evidence for a newly discovered cellular anti-HIV phenotype
    • Simon, J. H., Gaddis, N. C., Fouchier, R. A. & Malim, M. H. Evidence for a newly discovered cellular anti-HIV phenotype. Nature Med. 4, 1397-1400 (1998).
    • (1998) Nature Med. , vol.4 , pp. 1397-1400
    • Simon, J.H.1    Gaddis, N.C.2    Fouchier, R.A.3    Malim, M.H.4
  • 96
    • 0031797865 scopus 로고    scopus 로고
    • An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
    • Madani, N. & Kabat, D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72, 10251-10255 (1998).
    • (1998) J. Virol. , vol.72 , pp. 10251-10255
    • Madani, N.1    Kabat, D.2
  • 97
    • 0031927202 scopus 로고    scopus 로고
    • Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100
    • Labrosse, B. et al. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100. J. Virol. 72, 6381-6388 (1998).
    • (1998) J. Virol. , vol.72 , pp. 6381-6388
    • Labrosse, B.1
  • 98
    • 0032815929 scopus 로고    scopus 로고
    • Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection
    • Murakami, T. et al. Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection. J. Virol. 73, 7489-7496 (1999).
    • (1999) J. Virol. , vol.73 , pp. 7489-7496
    • Murakami, T.1
  • 99
    • 0034625144 scopus 로고    scopus 로고
    • A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
    • Dragic, T. et al. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl Acad. Sci. USA 97, 5639-5644 (2000).
    • (2000) Proc. Natl Acad. Sci. USA , vol.97 , pp. 5639-5644
    • Dragic, T.1
  • 100
    • 0033521097 scopus 로고    scopus 로고
    • Inhibition of G-protein coupled receptor functions by disruption of transmembrane domain interactions
    • Tarasova, N. I., Rice, W. G. & Michejda, C. J. Inhibition of G-protein coupled receptor functions by disruption of transmembrane domain interactions. J. Biol. Chem. 274, 34911-34915 (1999).
    • (1999) J. Biol. Chem. , vol.274 , pp. 34911-34915
    • Tarasova, N.I.1    Rice, W.G.2    Michejda, C.J.3
  • 102
    • 0030970693 scopus 로고    scopus 로고
    • Core structure of gp41 from the HIV envelope glycoprotein
    • Chan, D. C., Fass, D., Berger, J. M. & Kim, P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273 (1997).
    • (1997) Cell , vol.89 , pp. 263-273
    • Chan, D.C.1    Fass, D.2    Berger, J.M.3    Kim, P.S.4
  • 103
    • 0032541424 scopus 로고    scopus 로고
    • Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41
    • Caffrey, M. et al. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J. 17, 4572-4584 (1998).
    • (1998) EMBO J. , vol.17 , pp. 4572-4584
    • Caffrey, M.1
  • 104
    • 0033525590 scopus 로고    scopus 로고
    • Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
    • Farzan, M. et al. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96, 667-676 (1999).
    • (1999) Cell , vol.96 , pp. 667-676
    • Farzan, M.1
  • 105
    • 0033920212 scopus 로고    scopus 로고
    • Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
    • Moulard, M. et al. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74, 1948-1960 (2000).
    • (2000) J. Virol. , vol.74 , pp. 1948-1960
    • Moulard, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.